U.S. market Closed. Opens in 2 hours 15 minutes

ACXP | Acurx Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses14.58M12.09M12.81M4.60M5.93M
Selling, General & Admin8.53M7.34M10.78M2.40M2.42M
Research & Development6.04M4.75M2.03M2.20M3.51M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-14.58M-12.09M-12.88M-4.60M-5.93M
Other Expenses / Income2.001.22K133.01K2.00-3.00
Before Tax Income-14.58M-12.09M-12.75M-4.60M-5.93M
Income Tax Expenses-14.58K-1.22K-66.50K-4.60K-5.93K
Net Income-14.58M-12.09M-12.68M-4.60M-5.93M
Interest ExpensesN/A-1.22KN/AN/AN/A
Basic Shares Outstanding12.67M10.82M10.22M9.92M9.92M
Diluted Shares Outstanding12.67M10.82M10.22M9.92M9.92M
EBITDA-14.58M-12.09M-12.88M-4.60M-5.93M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-14.59M-12.09M-12.75M-4.60M-5.94M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙